These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14709956)

  • 41. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new clinical protocol for the pharmacological management of acute behavioural disturbance.
    Emmerson B; Moudgil V; Woodbridge A; Burrows D; Kingswell B; Kubler P; McMahon K
    Australas Psychiatry; 2011 Oct; 19(5):406-9. PubMed ID: 21995354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intramuscular aripiprazole in the acute management of psychomotor agitation.
    De Filippis S; Cuomo I; Lionetto L; Janiri D; Simmaco M; Caloro M; De Persis S; Piazzi G; Simonetti A; Telesforo CL; Sciarretta A; Caccia F; Gentile G; Kotzalidis GD; Girardi P
    Pharmacotherapy; 2013 Jun; 33(6):603-14. PubMed ID: 23505124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication.
    Chaichan W
    J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: results from NATURA study].
    Escobar R; San L; Pérez V; Olivares JM; Polavieja P; López-Carrero C; Casillas M; Montoya A
    Actas Esp Psiquiatr; 2008; 36(3):151-7. PubMed ID: 18478455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comparative efficacy of intramuscular antipsychotics for the management of acute agitation.
    Bosanac P; Hollander Y; Castle D
    Australas Psychiatry; 2013 Dec; 21(6):554-62. PubMed ID: 23996795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.
    Wilson MP; MacDonald K; Vilke GM; Feifel D
    J Emerg Med; 2012 Nov; 43(5):889-96. PubMed ID: 20542400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is relapse a justification for the use of high-dose antipsychotics?
    Cohen S; Chiles JA
    J Clin Psychiatry; 1990 Nov; 51(11):486-7. PubMed ID: 1977741
    [No Abstract]   [Full Text] [Related]  

  • 50. Parenteral treatment of acute psychotic patients with agitation: a review.
    Fruensgaard K
    Curr Med Res Opin; 1978; 5(8):593-600. PubMed ID: 30596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of orally disintegrating olanzapine on use of intramuscular antipsychotics, seclusion, and restraint in an acute inpatient psychiatric setting.
    Simpson JR; Thompson CR; Beckson M
    J Clin Psychopharmacol; 2006 Jun; 26(3):333-5. PubMed ID: 16702903
    [No Abstract]   [Full Text] [Related]  

  • 52. Olanzapine long-acting injection: When and for how long is oral supplementation required?
    Chew MS; Dhillon R; Tibrewal P; Narang B
    Aust N Z J Psychiatry; 2013 Dec; 47(12):1214-5. PubMed ID: 23928272
    [No Abstract]   [Full Text] [Related]  

  • 53. Chlorpromazine for psychosis-induced aggression or agitation.
    Ahmed U; Jones H; Adams CE
    Schizophr Bull; 2011 Sep; 37(5):890-1. PubMed ID: 21860034
    [No Abstract]   [Full Text] [Related]  

  • 54. Benzodiazepines and acute psychotic agitation.
    Benazzi F; Mazzoli M; Rossi E
    Can J Psychiatry; 1992 Dec; 37(10):732-3. PubMed ID: 1361879
    [No Abstract]   [Full Text] [Related]  

  • 55. Intravenous Olanzapine for the Management of Agitation: Review of the Literature.
    Khorassani F; Saad M
    Ann Pharmacother; 2019 Aug; 53(8):853-859. PubMed ID: 30758221
    [No Abstract]   [Full Text] [Related]  

  • 56. Intravenous olanzapine--another option for the acutely agitated patient?
    Chan EW; Knott JC; Taylor DM; Phillips GA; Kong DC
    Emerg Med Australas; 2009 Jun; 21(3):241-2. PubMed ID: 19527287
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.
    Swartz MS; Perkins DO; Stroup TS; McEvoy JP; Nieri JM; Haak DC
    Schizophr Bull; 2003; 29(1):33-43. PubMed ID: 12908659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia.
    Amodeo G; Fagiolini A; Sachs G; Erfurth A
    CNS Neurol Disord Drug Targets; 2017; 16(8):885-890. PubMed ID: 28933260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Inhalative loxapine: old tried and trusted medication with new indications].
    Juckel G
    Nervenarzt; 2013 Sep; 84(9):1113-4, 1116. PubMed ID: 23846335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Proposal for Latin America of an algorithm for the management of agitated patients with olanzapine and its switch to oral administration].
    Tamayo J; David S; Pacheco A; Lugo F; Solórzano L
    Vertex; 2003; 14(51):5-15. PubMed ID: 12690404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.